USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12307
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMusteata, Vasile
dc.contributor.authorStratan, Valentina
dc.contributor.authorCatrinici, Larisa
dc.contributor.authorMusteata, Larisa
dc.contributor.authorDudnic, Cristina
dc.date.accessioned2020-10-26T12:18:11Z
dc.date.available2020-10-26T12:18:11Z
dc.date.issued2020
dc.identifier.citationMUSTEATA, Vasile, STRATAN, Valentina, CATRINICI, Larisa, et al. Management of elderly patients with chronic myeloproliferative hemopathies. In: The Moldovan Medical Journal. 2020, vol. 63, no 6, pp. 12-15. ISSN 2537-6381. DOI: 10.5281/zenodo.4028363en_US
dc.identifier.issn2537-6381
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2020/10/63-6-00-Spaltul-3-din-06-10-20-final.pdf
dc.identifier.urihttps://doi.org/10.5281/zenodo.4028363
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12307
dc.descriptionDiscipline of Hematology, Nicolae Testemitanu State University of Medicine and Pharmacy Laboratory of Immunology and Molecular Genetics, Department of Hematology Institute of Oncology, Chisinau, the Republic of Moldova. The 75th anniversary of Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova (1945-2020)en_US
dc.description.abstractBackground: Chronic myeloproliferative hemopathies (CMPH) as a whole are the most common chronic leukemias in the elderly in the structure of morbidity by hematological malignancies with primary bone marrow involvement, being characterized in the advanced stages by a severe, recurrent evolution and unfavorable prognosis, with negative socio-economic impact. Material and methods: A clinical, analytical, and descriptive study was carried out along with the narrative review of the international literature on the subject. The study enrolled 91 elderly patients with different phases of chronic myeloid leukemia (CML), primary myelofibrosis (PMF) and polycythemia vera (PV), who were followed up and treated at the Institute of Oncology in the period of 1995–2020. According to the impact score, 25 relevant primary sources were identified and selected having a scientific, reproducible and transparent approach to the relevant subject, followed by data extraction and analysis. Results: The overall one- and 5-year survival in patients aged greater than or equal to 60 years old treated with tyrosine kinase inhibitors (TKIs) was 97.6 and 79%, being lower as compared with the same indices in the totality of CML. In elderly PV patients the overall 5-and 10-year survival made up 93.5% and 76.4%, being lesser than registered in all patients with PV. As reported in the recent references, a significant rate of patients with CMPH underwent reduced working hours, discontinued employment, and medical disability: PMF – 38%, 35%, 33%, and PV – 33%, 28%, and 15%, respectively. Conclusions: The long-term treatment results in elderly patients with CMPH fail compared to those in the CMPH totality, due to the development of age-related diseases and vascular accidents caused by leuko- and thrombocytosis.en_US
dc.language.isoenen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldova
dc.relation.ispartofThe Moldovan Medical Journal: The 75th anniversary of Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova (1945-2020)
dc.subjectmyeloproliferative hemopathiesen_US
dc.subjectmyeloid leukemiaen_US
dc.subjectmyelofibrosisen_US
dc.subjectpolycythemia veraen_US
dc.subjectelderly patientsen_US
dc.subject.ddcUDC: 616.155.392.8-036.12-053.9en_US
dc.titleManagement of elderly patients with chronic myeloproliferative hemopathiesen_US
dc.typeArticleen_US
Appears in Collections:The Moldovan Medical Journal, Vol. 63, No 6, December 2020



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback